Concord Biotech Limited (CONCORDBIO) — Free Cash Flow Generation Index
Concord Biotech Limited (CONCORDBIO) has a Free Cash Flow Generation Index of 0.55x as of March 2025. Free cash flow of Rs1.36 Billion represents 1% of operating cash flow (Rs2.47 Billion). See Concord Biotech Limited working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Concord Biotech Limited Free Cash Flow Generation Index (2020–2025)
Historical FCF Generation Index trend for Concord Biotech Limited across 6 annual periods. Explore Concord Biotech Limited debt service capacity to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Concord Biotech Limited (2020–2025)
Year-by-year Free Cash Flow Generation Index for Concord Biotech Limited. For the full company profile including market capitalisation, see Concord Biotech Limited (CONCORDBIO) market capitalisation.
| Year | FCG Index | Free Cash Flow (INR) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.55x | Rs1.36 Billion | Rs2.47 Billion | Rs1.11 Billion | ▼ -18.7% |
| 2024 | 0.68x | Rs1.80 Billion | Rs2.65 Billion | Rs856.88 Million | ▲ +65.1% |
| 2023 | 0.41x | Rs1.01 Billion | Rs2.46 Billion | Rs1.45 Billion | ▲ +63.8% |
| 2022 | 0.25x | Rs519.70 Million | Rs2.07 Billion | Rs1.56 Billion | ▲ +211.8% |
| 2021 | -0.22x | Rs-373.59 Million | Rs1.67 Billion | Rs2.04 Billion | ▼ -5466.2% |
| 2020 | 0.00x | Rs-6.23 Million | Rs1.55 Billion | Rs1.55 Billion | — |